#CBD Market

[cportmerch]

JKDISTRO Welcome Sampler

Free Welcome Sample from JKDISTRO. Just pay shipping. https://jkdistro.com/?sld=cport

[fuckyeahomsk]

An open market in Omsk is an economic system with little to no barriers to free-market activity ( ノ ^o^)ノ

[ladytanithia]

In case y'all didn't know, there's a CBD dispensary in Charlottesville, SC, that sells Skooma brand products, and also Moonsugar items like bath bombs and massage oil. The more you know!

(No, I don't work for them, I've never bought anything from them, and I'm not trying to advertise them, just putting it out there as a case of interest.)

[bunnybevvyy]

Yesterday, the vibes were immaculate almost everywhere we went.

[webmackin]

Why LiveGood?

Please allow me to get direct to the point: As you probably already know, I’ve been in network marketing for sometime now and probably just like you, I have a love / hate relationship with it. 🫣 Examples : ✅Love the relationships and friendships that come out of it .🫶🏽✅Love being able to dream again .🫶🏽✅Love self development .💪🏽🫶🏽💪🏽 Not so much loving ⬇️ ❌Over Priced products ! 😡😳❌Politics…

[mikemerz]

Mike Long + David Mills (Green Gold cannabinoid affiliate marketing training & business in a box launch high-ticket affiliate program registration page), Buzz Builders, and More … in Today’s thars gold in that thar green edition of the JVNP 2.0 Update.

Have a Great Day! ;)

– Mike Merz Sr

[chetanagblog]

The CBD Gummies Market size was valued at USD 3.45 Billion in 2023 and the total CBD Gummies revenue is expected to grow at a CAGR of 29.2% from 2024 to 2030, reaching nearly USD 20.73 Billion.

[savibangar]

CBD-infused Products Market — Global Forecast to 2031

[sabrinawillson03]

The Growing Cannabidiol (CBD) Market in Mexico: A CAGR of 26.60% Forecasted from 2024 to 2032

The cannabidiol (CBD) market in Mexico has experienced significant growth in 2023, marking a pivotal moment for the emerging cannabis industry in the country. As consumer awareness around the benefits of CBD products continues to expand, Mexico's CBD market is poised for substantial growth in the coming years. According to recent estimates, the market is expected to grow at a compound annual growth rate (CAGR) of 26.60% between 2024 and 2032. This growth trajectory highlights the increasing demand for CBD products in Mexico and positions the country as a key player in the global CBD market.

A Snapshot of the CBD Market in Mexico

Cannabidiol, a non-psychoactive compound derived from the cannabis plant, has gained popularity worldwide for its potential health benefits. In Mexico, the market for CBD products, including oils, tinctures, edibles, creams, and capsules, has grown steadily, fueled by both local and international demand. In 2023, the Mexican CBD market saw notable advancements, including the easing of regulatory frameworks and a growing interest in natural wellness products.

While the legal landscape for cannabis products in Mexico is still evolving, the government has made significant strides toward the acceptance and regulation of CBD products. Mexico legalized the use of CBD products containing less than 1% THC in 2017, opening the door for both domestic production and importation of CBD products. Additionally, discussions around the broader legalization of cannabis have increased, creating further potential for market expansion.

Factors Driving the Growth of the CBD Market in Mexico

Several factors are contributing to the rapid growth of the CBD market in Mexico, and these can be attributed to both domestic and global trends. Below are the key drivers:

1. Growing Consumer Awareness of CBD Benefits

One of the most significant factors contributing to the market's growth is the increasing awareness among Mexican consumers about the potential health benefits of CBD. Many people are turning to CBD as a natural alternative to pharmaceuticals for managing various health conditions, such as anxiety, chronic pain, sleep disorders, and inflammation. The rising awareness of these benefits is fueling demand for CBD-based wellness and personal care products across the country.

2. Expanding Retail Channels

CBD products are now more accessible to Mexican consumers than ever before. The rise of e-commerce platforms, coupled with the growing availability of CBD in health and wellness stores, pharmacies, and even supermarkets, has expanded the reach of CBD products. Major retail chains in Mexico are starting to carry CBD products, making them more visible and accessible to consumers. This has led to a surge in sales, especially among the health-conscious and those seeking natural alternatives to conventional medicines.

3. Regulatory Developments and Legalization

Mexico has made considerable progress in regulating the cannabis industry, particularly CBD. The legalization of CBD products containing less than 1% THC in 2017 was a key step in enabling the market's growth. In 2021, Mexico also passed a law allowing the use of cannabis for medicinal purposes, further contributing to the positive regulatory environment for CBD products. While the full legalization of recreational cannabis is still in progress, these regulatory changes are laying the foundation for increased market growth in the years to come.

4. International Market Influence

Mexico’s CBD market is also benefiting from global trends. The rising demand for CBD products in North America, particularly the U.S., has influenced the Mexican market. As CBD continues to gain traction in international markets, companies in Mexico are increasingly looking to meet the demand for CBD products, both domestically and for export.

5. Product Innovation and Variety

The range of CBD products available to Mexican consumers is expanding rapidly. In addition to traditional CBD oils and tinctures, Mexican consumers now have access to a wide variety of CBD-infused products such as gummies, beverages, skincare items, and even pet products. As companies innovate to offer diverse options that appeal to different segments of the market, consumer interest in CBD products continues to rise.

Challenges Facing the CBD Market in Mexico

While the CBD market in Mexico shows promising growth potential, there are several challenges that could impact its development in the coming years.

1. Regulatory Uncertainty

Despite the progress made in regulating CBD, there are still some regulatory hurdles to overcome. The legal framework for cannabis products in Mexico remains somewhat ambiguous, particularly regarding the cultivation, production, and sale of cannabis for recreational use. Full legalization and clearer regulations could enhance market stability and encourage further investments in the CBD sector.

2. Limited Education and Misinformation

Although consumer awareness is growing, there is still a degree of misinformation surrounding CBD and cannabis products in Mexico. Public education about the difference between CBD and THC, as well as the health benefits of CBD, is essential to dispel myths and concerns. Misinformation could hinder the adoption of CBD products among certain consumer groups, slowing the market’s growth.

3. Importation and Supply Chain Issues

The supply chain for CBD products in Mexico is largely reliant on imports, particularly from countries like the United States and Canada. This reliance on international sources could expose the market to potential disruptions, such as changes in trade policies or issues related to product quality and sourcing. Domestic production of CBD could alleviate some of these concerns but is still in the early stages.

4. Competition from the Illegal Market

While CBD products are legal in Mexico, there remains a significant challenge in the form of the illegal cannabis market. In some areas, black-market cannabis and CBD products are still prevalent, and consumers may be more inclined to purchase cheaper, unregulated products. This can lead to concerns about product safety and quality, further hindering the growth of the legal CBD market.

The Future Outlook of the CBD Market in Mexico

The future of the CBD market in Mexico looks incredibly promising, with continued growth expected over the next decade. The market is forecast to grow at a CAGR of 26.60% from 2024 to 2032, reaching an estimated value of billions of dollars by the end of the forecast period. This growth will be driven by a combination of factors, including increased consumer demand for natural health products, expanded product offerings, and a more supportive regulatory environment.

Potential Growth in Consumer Segments

The demand for CBD products in Mexico is expected to continue growing across several consumer segments, including:

Health and Wellness Consumers: The growing interest in natural and alternative health products will continue to drive demand for CBD oils, tinctures, and edibles.

Beauty and Skincare Market: As more people turn to CBD-infused skincare products, the beauty industry in Mexico will likely see a boom in CBD-based cosmetics and treatments.

Pet Care: The pet care sector is also beginning to embrace CBD, with CBD-infused products for pets being introduced to the market, offering potential for growth.

Advancements in Domestic Production

As the market matures, Mexico is likely to see an increase in domestic production of CBD products. This would reduce reliance on imports, help stabilize the supply chain, and potentially lower product costs. Domestic cultivation of hemp and cannabis for CBD extraction could open up new economic opportunities, particularly in rural areas.

Expansion of Legal Frameworks

With the continued momentum toward cannabis legalization, the broader legalization of recreational cannabis in Mexico could further boost the CBD market. Once fully regulated, the market could see an influx of new players, more investment, and a wider variety of products available to consumers.

[waledxman123]

Pfizer and Tilray: Contrasting Stock Movements Spark Investor Interest

The financial and investment landscape recently spotlighted significant developments in the stock movements of Pfizer Inc. (NYSE:PFE) and Tilray Brands Inc. (NASDAQ:TLRY). These activities have shed light on the evolving dynamics in the pharmaceutical and cannabis industries, drawing attention from institutional and individual investors alike.

Pfizer: A Mixed Bag of Investor Sentiment

Acquisition by Rep. Laurel M. Lee Rep. Laurel M. Lee disclosed a recent acquisition of Pfizer stock, signaling confidence in the pharmaceutical giant’s long-term prospects. Pfizer, a household name due to its role in combatting COVID-19, continues to leverage its expansive portfolio beyond vaccines. Current endeavors focus on oncology, rare diseases, and innovations in antiviral treatments. This move by Lee highlights a potential faith in Pfizer’s strategic pivots and innovation-focused future, despite recent challenges in revenue growth​

read more in google news

3. Pfizer’s Broader Challenges Despite these contrasting stock activities, Pfizer’s fundamentals remain strong. With a robust pipeline of drugs, the company is poised to capitalize on innovations in gene therapy and precision medicine. Additionally, its strategic acquisitions aim to offset losses from expiring patents. However, the road to sustained growth appears challenging, given the current macroeconomic environment and evolving healthcare demands.

read more in google news

Tilray: Strategic Diversification Amid Industry Volatility

Tilray’s Stock Performance Tilray Brands, a global leader in cannabis and consumer-packaged goods, has witnessed significant investor interest due to its strategic initiatives. The company’s stock has been influenced by its aggressive expansion into non-cannabis sectors, including beverages and wellness products. These moves reflect Tilray’s efforts to weather the volatility of the cannabis market and regulatory hurdles in the United States and beyondough Diversification** Tilray’s ability to adapt has been pivotal. The company has strengthened its foothold by acquiring prominent beverage brands and expanding into THC and CBD-infused products. Its partnerships across North America and Europe underscore its vision for long-term growth in a market where legalization trends are gaining momentum. Tilray’s performance has also been bolstered by its entry into consumer-packaged goods, providing a hedge against the slower-than-expected legalization of recreational cannabis in the U.S. .

3. Industrynges Despite these efforts, Tilray faces headwinds. Oversupply issues in the cannabis market, fluctuating product prices, and fragmented regulations remain significant barriers. While the company is capitalizing on its international footprint, the U.S. remains a critical market for future growth. Investors are closely monitoring developments in federal legalization efforts, which could provide a substantial tailwind for Tilray’s ambitions.

read more in google news

Investor Takeaways: Contrasting Dynamics in Key Sectors

The contrasting approaches to Pfizer and Tilray stocks highlight broader themes in their respective industries:

Pharmaceuticals: Pfizer’s stock movements reflect both optimism about its innovative pipeline and concerns about its near-term revenue challenges. The company’s ability to execute its post-pandemic strategy will be critical to regaining investor confidence.

Cannabis: Tilray’s story underscores the importance of strategic diversification and adaptability in a nascent yet volatile industry. While challenges persist, the company’s proactive steps toward market expansion position it well for future growth.

These developments underscore the complexity of investing in dynamic, highly regulated sectors where innovation, strategy, and market sentiment intersect.

[anjupro]

Top Industrial Snapshot of Cannabidiol (CBD) Consumer Health Market 2025

The Cannabidiol (CBD) Consumer Health Market Report is a treasured source of insightful data for business strategists. It provides an in-depth assessment of numerous features of industries like market overview, present progress valuations, historical and future Studies, current trends, SWOT valuations, and clients operating in several regions. The study provides valuable information to magnify the understanding, scope, and segments of this report. The report covers a comprehensive analysis of Cannabidiol (CBD) Consumer Health Market segmentation, regional and country breakdowns. This research will offer a clear and exact idea about the whole industry to the readers to make beneficial decisions.

According to Straits Research, the global Cannabidiol (CBD) Consumer Health market size was valued at USD 15.78 Billion in 2022. It is projected to reach from USD XX Billion in 2023 to USD 112.58 Billion by 2031, growing at a CAGR of 24.4% during the forecast period (2023–2031).

This study pinpoints noteworthy trends influencing the trajectory of the Gesture Recognition market's expansion. Within this recently issued report, crucial dynamics encompassing drivers, limitations, and prospects are underscored. These aspects hold relevance for well-established market entities as well as emerging stakeholders engaged in the realms of production and supply.

Request a Sample Report @ https://straitsresearch.com/report/cannabidiol-consumer-health-market/request-sample

Competitive Analysis

The report contains an in-depth analysis of the vendor’s profile, including financial health, business units, key business priorities, SWOT, strategies, and views.

Elixinol Global Limited

ENDOCA

Kazmira

Charlotte's Web

Joy Organics

NuLeaf Naturals LLC

Lord Jones

CV Sciences Inc

Isodiol International Inc

Medical Marijuana Inc

The vendors have been identified based on the portfolio, geographical presence, marketing & distribution channels, revenue generation, and significant R&D investments.

Request Sample Report of Global Cannabidiol (CBD) Consumer Health Market @ https://straitsresearch.com/report/cannabidiol-consumer-health-market/request-sample

[researchrealmblog]

North America is Dominating the CBD Oil Market 

In 2022, the CBD oil market size stood at USD 5,230.9 million, which is projected to witness a 20.8% CAGR during 2022–2030, reaching USD 23,720 million by 2030 as per P&S Intelligence. 

CBD is a chemical found in the cannabis Sativa plant and removed from cannabis or hemp. Hemp is a more popular feedstock since it contains more CBD. Because of its beneficial properties, the need for CBD in the wellness and health industry is growing. Furthermore, the mounting use of CBD-rich items because of government approvals for recreational, medical, and R&D purposes is the main reason projected to fuel their production.

The marijuana category is projected to surge at a CAGR of 22% and is also estimated to continue its dominance in the future as well. The growing acceptance of purified CBD products and the rising legalization of marijuana-resulting items for numerous research and medical purposes are the main factors contributing to the growth of the category. For example, ancient Indian Ayurvedic methods used cannabis as a vital element in medicine for the betterment of blood pressure and digestion.

The hemp category is estimated to experience moderate growth in the coming years. This growth is majorly credited to the increasing need for hemp in the medicinal sector and rising awareness among consumers of fitness and health, along with the snowballing customer income and legalization of cannabis.

Furthermore, industrial hemp seeds hold calories, protein, and other nutrients. Individuals use it mostly for dieting, constipation, eczema, and other purposes. Numerous industries, including food and beverages, personal care, and cosmetics are using such seeds to grow products for health, wellness, and fitness.

In 2022, the B2B category led the market, with the highest revenue share of 52%, and is projected to continue its dominance in the years to come. This can be ascribed to the increasing number of investors, wholesalers, and producers of CBD oil products.

The demand is also snowballing due to the cannabidiol products requirement mounting in numerous industries, including cosmetics sectors, health, and wellness, and food and additives, the medications sector has amplified the demand for businesses to procure cannabidiol precursor material for their product in bulk.

North America held the highest revenue share of above 84% and is projected to continue its dominance in the coming years also. This growth can be credited to the authorization of cannabidiol for therapeutic and research purposes in the region. The position of the item as a natural phytocompound, its robust promotion by companies as a lifestyle and wellness item, the introduction of cannabidiol-based medicines, including Sativex and Epidiolex, and the extensive availability of numerous products comprising this compound are further projected to surge the sale of cannabidiol oil in the continent in the future.

Hence, the need for CBD in the wellness and health industry is growing, and the mounting use of CBD-rich items because of government approvals for recreational, medical, and R&D purposes is a major factor that will drive the CBD oil market in the future. 

Source: P&S Intelligence